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A COMPARISON OF COMMUNITY-BASED CENTERS VERSUS
UNIVERSITY-BASED CENTERS IN CLINICAL TRIAL PERFORMANCE
Cynthia R. Stockdale
ABSTRACT
The success of a clinical trial is largely dependent on the clinical sites that enroll
the subjects, complete the follow-up visits, and collect the data. Many clinical trials are
conducted using multiple site locations. Choosing such sites to participate in a clinical
trial is an important aspect of study implementation. In the past, multi-center clinical
trials were conducted mainly using university-based centers. In the last few decades,
private practice, or community-based, centers have been included more often in clinical
trial research. As more community-based centers participate in clinical trials, it is crucial
to examine how these centers might differ from university-based centers.
The purpose of this project was to compare community-based and universitybased centers participating in a multi-center randomized trial evaluating treatments for
diabetic macular edema. Aspects of recruitment, retention, protocol adherence, data
collection, and observance of study required procedures were compared.
Data from 102 participating centers were examined with 40 centers categorized as
university-based and 62 centers categorized as community-based. Various measures of
trial performance were compared using Wilcoxon rank-sum test, repeated measures
logistic regression, and repeated measures analysis of variance (ANOVA), depending on
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the variable being compared. Characteristics of the centers and baseline subject
characteristics were compared to evaluate for possible confounding.
We found that university-based and community-based centers performed similarly
in almost all performance aspects compared. Notable differences included communitybased centers becoming certified for participation in the study 90 days sooner on average
and university-based centers having half the percentage of ungradable fundus
photographs. Overall, it is recommended that community-based centers be included
more often in multi-center clinical trials.
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CHAPTER 1. INTRODUCTION
Background
The success of a clinical trial is largely dependent on clinical centers that enroll the
subjects in a reasonable time, complete the follow-up visits within stated windows, and
collect the data according to the protocol. Many clinical trials are conducted using multiple
center locations. Choosing such centers to participate in a clinical trial is an important aspect
of study implementation. In the past, multi-center clinical trials have been conducted mainly
at non-profit university-based centers, with clinician-investigators whose research interest
and purpose for seeing patients within the university setting was clinical trials. In the last
few decades, community-based centers (sometimes called “private practice sites”) have been
included more often in clinical trials in an effort to increase subject accrual rates, broaden the
pool of potential subjects, streamline contractual arrangements with a smaller entity than a
university, and centralize institutional review board activities, an option not available for
many university-based centers. As more community-based centers become involved in
clinical trials, it is crucial to examine how these sites might differ from university-based
centers in trial performance.
Diabetic Retinopathy Clinical Research Network
The Diabetic Retinopathy Clinical Research Network (DRCR.net) is a collaborative
group dedicated to conducting multi-center clinical trials of diabetic retinopathy and its
1

associated conditions. DRCR.net is funded by the National Institutes of Health (specifically
the National Eye Institute), which is a branch of the federal government. The Network was
created in order to facilitate evaluation of new treatments for diabetic retinopathy by
developing an infrastructure of participating clinical centers organized and prepared to study
new treatment approaches as soon as they become available.(Diabetic Retinopathy Clinical
Research Network)
From its inception in 2002, the DRCR.net encouraged all clinical centers with access
to the necessary equipment to conduct diabetic retinopathy clinical trials to apply for
participation. Other requirements for a clinical center to participate in the Network include a
qualified investigator, coordinator, photographer, visual acuity technician, and optical
coherence tomography (OCT) technician. A qualified investigator has either completed a
one year retina fellowship or has completed three years in clinical practice with at least 50%
retinal patients. Currently, the DRCR.net consists of 112 active centers and 329 active
investigators from 38 states throughout the United States. The open participation concept of
the DRCR.net allowed a multi-center network consisting of both university-based and
community-based centers to be created, providing a unique opportunity to evaluate how
center type affects the conduct of clinical trials.
Summary of DRCR.net Randomized Trial
Currently, the DRCR.net has five completed studies, three studies currently in the
follow-up phase, and two studies currently recruiting. The data used for the current study are
from the second randomized trial initiated by the Network entitled, ‘A Randomized Trial
Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic
Macular Edema.’ The trial is currently in its follow-up phase and the data for this analysis
2

are current as of February 1, 2008. The purpose of the trial is to compare injections into the
eye of triamcinolone acetonide with laser treatment for diabetic macular edema. The study
involves required follow-up visits at 4-month intervals with additional visits in between when
necessary for care of the subject. The primary outcome visit is at 2 years, and at the time of
this analysis, approximately two-thirds of subjects had reached this time point. Data
collected at each follow-up visit includes an ocular examination, visual acuity testing, and
optical coherence tomography (referred to as OCT) which uses a dim beam of light to
measure the thickness of the retina. Special photographs of the retina and lens (referred to as
fundus photographs) are also taken annually. The majority of the data is entered at the time
of the visit directly on the DRCR.net study website using electronic case report forms. Any
edits to the case report forms during the course of the trial are tracked. The data are then
monitored by the Coordinating Center for any deviations from protocol. At regular intervals,
investigators are required to sign-off on the case report form data that are entered, any edits
made, and any protocol deviations the Coordinating Center has identified. Centers are also
required to ship the OCT images and fundus photographs to a Fundus Photograph Reading
Center (FPRC) within 28 days of obtaining the image or photograph.
Purpose of Current Study
The purpose of this study is to compare clinical trial performance of university-based
centers and community-based centers participating in a phase III clinical trial being
completed by the Diabetic Retinopathy Clinical Research Network entitled, ‘A Randomized
Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for
Diabetic Macular Edema.’ Aspects of participation, recruitment, retention, and protocol
3

adherence in the two groups of centers were compared. It is important to note that the
majority of centers in this analysis also participated in the Network’s inaugural study, which
was aimed to evaluate different types of laser treatments. This allowed centers to become
familiar with the Network procedures such as electronic case report form entry, measurement
of visual acuity with the Electronic Visual Acuity Tester, transmission of photographs and
optical coherence tomography images (OCTs) to the Fundus Photograph Reading Center
before beginning the phase 3 drug trial. Therefore, the centers being compared in the current
study had prior opportunity to adapt to the Network specific study procedures being
evaluated.
The purpose of this project was not to determine if one type of center should be
included in clinical trials over another. The project was aimed to determine which aspects of
trial conduct might be deficient in one type of center so that these deficiencies can be
addressed and improved upon in the future. Furthermore, if it is found that community-based
centers perform as well or better than university-based centers, the use of these types of
centers in government and industry-sponsored large clinical trials may be increased.
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CHAPTER 2. LITERATURE REVIEW
Oncologic Clinical Trials
There is limited published literature evaluating the conduct of clinical trials at
community-based centers compared with university-based centers. The first published
evaluations of the clinical trial performance of community-based centers were in multi-center
oncology trials. In the late seventies, community hospitals and community-based centers
were first being included in large cooperative oncology groups under direction from the
National Cancer Institute, which emphasized inclusion of all potential subjects in their
studies.(Koretz, Jackson, Torti, & Carter, 1983)
The Eastern Cooperative Oncology Group (ECOG), which consisted only of
university hospitals and large treatment centers, began involving community affiliates in
1976.(Begg, Carbone, Elson, & Zelen, 1982) Community affiliates were either smaller
hospitals or community-based centers. Since these community affiliates had little or no
experience conducting clinical trials previously, their compliance with the protocols and
study outcome data were compared with the member institutions to determine whether the
objectives of the studies were being met at these new centers. Begg, et al, found that the
member institutions had significantly lower ineligibility and protocol-violation rates than the
community affiliates. However, the authors believed the difference was not enough to make
any practical impact. Inadequate data submission was slightly lower in the community
affiliates compared with the member institutions. No difference was found in survival,
5

response to treatment, or toxicity. Overall, the authors concluded that community hospitals
should continue to be included in their clinical trials.(Begg et al., 1982)
A similar analysis by the Northern California Oncology group found that community
affiliates performed at least equally to the universities in all but one of the compared
aspects.(Koretz et al., 1983) The affiliates had a significantly lower proportion of evaluable
subjects based on secondary review of eligibility and treatment. This was mostly due to
differences in eligibility determination between the community physician and the central
study pathologist, which could be a result of the inexperience of the physicians in
determining eligibility. On the other hand, protocol adherence and data completeness rates
were higher for the community affiliates compared with the universities.(Koretz et al., 1983)
Ophthalmic Clinical Trials
A more recent publication compared community and university-based centers
conducting ophthalmic clinical trials.(Bressler et al., 2004) The data were from the
Submacular Surgery Trials Research Group, a multi-center research group conducting
clinical trials funded by the National Eye Institute. Out of 27 participating centers, 17 were
community-based and 10 were university-based. Percentage of total completed exams,
completed outcome exams, completed questionnaires as well as time to submit data to the
Coordinating Center and images to the Photograph Reading Center were compared. Using
only descriptive statistics due to the small number of centers, the authors found that overall
community-based centers performed approximately equally to that of university based
centers in trial performance with the majority of the centers performing at a high level.
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However, the few centers that performed inferiorly to the others tended to be communitybased centers. (Bressler et al., 2004)
Summary
Due to the limited available data on the subject, especially recently, it is anticipated
that this study will contribute greatly to the knowledge of clinical trial implementation at
university-based centers and community-based centers. As it is becoming increasingly more
common to include community-based centers in large clinical trial networks, it is crucial to
determine how the performance of these centers compares with university-based centers.
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CHAPTER 3. METHODS
Study Design
The current analysis is a retrospective examination of center-specific data collected
during a multi-center randomized trial being completed by the Diabetic Retinopathy Clinical
Research Network (DRCR.net) evaluating treatments for diabetic macular edema. The data
was prospectively collected as part of routine DRCR.net procedures. Outcome measures
used to evaluate clinical trial performance were based on real-time electronic data entry of
case report forms, edits, protocol deviations, and tracking of image shipments.
Eligibility Criteria
To be included in the analysis, centers had to have been certified in the randomized
trial of interest. Of 140 centers that expressed interest in participation, 102 centers were
certified. Certain analyses further excluded centers that were certified but never recruited
subjects (N = 14) leaving 88 centers remaining.
Data Collection
The trial began with the first center being certified in June 2004 and the first subject
randomization in July 2004. A total of 693 subjects were randomized between July 2004 and
May 2006. Data collection for these analyses spanned from July 2004 until February 2008.
For the baseline subject characteristics, demographic data and a complete medical history
was collected from each participant. A glycosylated hemoglobin level and visual acuity
8

testing results were also recorded. For the site characteristics, data from the 2000 US Census
were used to determine region, population and median annual household income for the city
in which the center was located.
Exposure Variable
The center type was self-reported by each center upon joining the Network and
verified by the Coordinating Center. In general, centers with institutional review boards are
categorized as university-based, as these centers are research oriented in purpose. These
centers also have a university official who completes the contract with the Coordinating
Center for performance of the clinical trial. Centers without institutional review boards are
generally categorized as community-based, as these centers are private practice oriented in
purpose.
Potential Confounders
Measures of site characteristics and baseline subject characteristics were compared
and evaluated for possible confounding. The two center types were also divided into low and
high subject recruitment categories to explore whether number of subjects was a confounding
factor affecting clinical trial performance.
Outcome Variables
Outcome variables were defined as follows:
•

Number of protocol deviations: Count of protocol deviations entered by the
Coordinating center per subject.
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•

Number of case report form edits: Count of changes made to electronic case
report forms per subject.

•

Number of data queries: Count of electronic queries from the Coordinating Center
to the center regarding data issues per subject.

•

Number of adverse events: Count of adverse event forms entered per subject.

•

Ungradable photographs and OCTs: Whether each photograph and OCT was
categorized by the Photograph Reading Center as ‘ungradable’ or not.

•

Number of recruited subjects: Count of subjects enrolled and randomized into the
trial at each center.

•

Percentage of completed visits: Percentage of follow-up visits required per
protocol that were completed; not including visits completed as part of the
subject’s usual care or visits completed following an injection to assess for safety
concerns.

•

Percentage of visits in-window: Completed protocol visits were categorized as inwindow or out-of-window based on whether they were completed during the
protocol-specified time period or “window” for each particular visit.

•

Primary outcome visit completion: Active subjects who were past the visit
window for the 2-year visit were categorized as having completed or not
completed the primary outcome visit. Subjects who were dropped prior to the
primary outcome visit were automatically categorized as not completing that visit.

•

Primary outcome visit in-window: 2-year visits that were completed were
categorized as being completed in-window or out-of-window.
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•

Dropped subjects: Subjects were categorized as dropped if a final status form was
completed by the site to discontinue participation in the study.

•

Number of days to become certified: Difference between the date the center
expressed interest in the protocol and the date the Coordinating Center certified
the center to begin recruiting subjects.

•

Number of investigators per center: Count of investigators who completed
Network requirements to be certified for participation in the study.

•

Number of conference calls attended by the Principal Investigator: Count of
monthly investigator conference calls for which the primary investigator is
required to attend at least a majority.

•

Number of conference calls attended by the Primary Coordinator: Count of
monthly coordinator conference calls for which the primary coordinator is
required to attend at least a majority.

•

Days until sign-off of case report forms: Difference between the date the case
report form was entered on the study website and the date the investigator
approved the data entry.

•

Days until sign-off of edits: Difference between the date the edit was made and
the date the investigator approved the edit.

•

Days until sign-off of deviations: Difference between the date the deviation was
entered by the Coordinating Center and the date the primary investigator
approved the deviation.
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•

Days until submission of photographs and OCTs: Difference between the time the
image was taken and the time the item was logged as ‘shipped’ on the study
website by the center.

Statistical Analyses
Statistical analyses were completed using SAS version 9.1. Summary statistics only
are presented for center and baseline subject characteristics, which were evaluated for
potential confounding. For outcome variables, the statistical test was chosen based on the
type of variable, and all p-values presented are 2-tailed. Normality of distributions was
evaluated and non-parametric tests were used where appropriate. Medians and interquartile
ranges are reported for all continuous variables to provide information on the distribution of
the data. Because of the limitations of multiple comparisons, only p-values <0.01 were
considered statistically significant.
Wilcoxon Test
Continuous variables that contained only one result per center were compared using
the nonparametric Wilcoxon test. These included days to become certified, number of
investigators per center, number of conference calls attended by the principal investigator
and primary coordinator, and number of recruited subjects per center.
Repeated Measures ANOVA
Subject-level continuous variables were compared using repeated measures ANOVA
to account for potentially correlated data from the same center. This included number of
protocol deviations, case report forms, data queries, and adverse events per subject;
12

percentage of completed protocol visits per subject; percentage of visits completed inwindow per subject; days until investigator sign-off of case report forms, protocol deviations,
case report form edits; and days until shipment of OCTs and photographs to the Fundus
Photography Reading Center.
Repeated Measures Logistic Regression
Binary variables with multiple results per center were compared using repeated
measures logistic regression with generalized estimating equations (GEE). This included
modeling the probability that the visit is completed and if completed, probability that the visit
is in-window. The probability that a subject is dropped was also modeled using repeated
measures logistic regression. Photograph and OCT quality were compared by modeling the
probability that an OCT or photograph was deemed ungradable by the Photograph Reading
Center.
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CHAPTER 4. RESULTS
Center and Subject Characteristics
The study included 102 certified centers. Forty centers were categorized as
university-based, and sixty-two centers were categorized as community-based. The
participating centers were located in 38 states with 42 centers from Southern states, 25 from
Midwestern states, 17 from Pacific states, 15 from Northeastern states, and 3 from Mountain
states (Table 1). The largest proportion of university-based centers was from the Midwest
(35%) whereas the largest proportion of community-based centers was from the South
(52%). According to 2000 U.S. Census data, the population of the cities in which the centers
were located ranged from 4,081 to 8,008,278 with the median population in cities of
university-based centers being 434,205 and the median population in cities of communitybased centers being 135,466 (Table 1). However, the recruitment pool for these centers is
not necessarily confined to the city limits so it is not clear whether this difference would
affect trial performance. The median annual household income for the cities in which the
centers were located was similar between university and community-based centers ($38,459
and $37,426 respectively).
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TABLE 1. CENTER CHARACTERISTICS ACCORDING TO CENTER TYPE*
CENTER CHARACTERISTICS

University Based

Community Based

N= 40

N = 62

Midwest

14 (35)

11 (18)

Mountain

1 (3)

2 (3)

Northeast

6 (15)

9 (15)

Pacific

9 (23)

8 (13)

South

10 (25)

32 (52)

Median (25th, 75th percentile)

434,205 (184,455,
624,064)

135,466 (42,068,
337,977)

[ range]

[9,019-8,008,278]

[4,081- 1,953,631]

Median (25th, 75th percentile)

$38,459 ($31,481,
$40,653)

$37,426 ($31,141,
$47,498)

[ range]

[$25,928-$72,057]

[$25,000-$91,162]

Region: n (%)

Population:

Population Income:

*Percentages do not equal 100 due to rounding

A total of 693 subjects were recruited at 88 of the participating centers with 207 recruited
at university-based centers and 486 recruited at community-based centers. Subjects at the
two types of centers were similar in age, gender, race, diabetes type, duration of diabetes,
baseline HbA1c, and baseline visual acuity (Table 2).
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TABLE 2. BASELINE SUBJECT CHARACTERISTICS ACCORDING TO CENTER TYPE†*
SUBJECT CHARACTERISTICS

University Based

Community Based

Ncenters = 35
Nsubjects = 207

Ncenters = 53
Nsubjects = 486

63 (57, 68)

63 (57, 70)

[38 – 84]

[30-86]

105 (51)

232 (48)

White

139 (67)

361 (74)

Hispanic or Latino

24 (12)

64 (13)

African-American

28 (14)

41 (8)

Asian

9 (4)

10 (2)

American Indian/ Alaskan Native

2 (<1)

3 (<1)

Native Hawaiian/Other Pacific Islander

0 (0)

1 (<1)

More than one race

1 (<1)

0 (0)

Unknown/not reported

4 (2)

6 (1)

Type 1

9 (4)

20 (4)

Type 2

188 (91)

422 (87)

10 (5)

44 (9)

16 (11, 23)

15 (10, 22)

[0.7-56]

[<.1-59]

7.7 (6.7,8.7)

7.5 (6.7, 8.6)

[5.1-14.4]

[4.1-16.3]

61 (50, 67)

59 (50, 66)

[27-73]

[24-73]

63 (54, 68)

62 (55, 67)

[24-73]

[25-73]

Age (yrs)
Median (25th, 75th percentile)
[ range]
Gender: Female - n (%)
Race: n (%)

Diabetes Type: n (%)

Uncertain
Duration of Diabetes (years):
Median (25th, 75th percentile)
[ range]
a

HbA1c :
Median (25th, 75th percentile)
[ range]
Study Eye Visual Acuity- Right Eye: (N=414)
Median (25th, 75th percentile)
[ range]
Study Eye Visual Acuity- Left Eye: (N=426)
Median (25th, 75th percentile)
[ range]
†

- only includes sites with randomized subjects (N=88)
* Percentages do not equal 100 due to rounding
a- 50 subjects are missing a baseline HbA1c
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Outcome Measures
Variables related to recruitment and retention were compared according to center type
(Table 3). Community-based centers recruited more subjects on average than universitybased centers (p = 0.05), but the difference did not meet the p <0.01 level for statistical
significance. There was no significant difference in percentage of completed protocol visits
per center or percentage of visits completed in-window per center. There was also no
significant difference in probability that a subject completes the primary outcome visit, that
the primary outcome visit is in window, or that the subject is dropped according to center
type.
TABLE 3. STUDY RECRUITMENT AND RETENTION ACCORDING TO CENTER TYPE
VARIABLE

University Based

Community Based

P-Value

Ncenters = 40
Nsubjects = 207

Ncenters = 62
Nsubjects = 486

4 (2, 9)

7 (3, 10)

[0-18]

[0-31]

95 (89, 99)

95 (93, 100)

[50-100]

[78-100]

86 (76, 93)

88 (82, 94)

[50-100]

[66-100]

127/165 (77)

290/387 (75)

0.57c

1˚ Outcome Visits Completed in Window† *:
n (%)

121/127 (95)

285/290 (98)

0.08c

Dropped Subjects†: n (%)

30/207 (14)

90/486 (19)

0.40c

Recruited Subjects per Center:
Median (25th, 75th percentile)
[ range]

0.05a

†

Completed Protocol Visits per Center (%) :
Median (25th, 75th percentile)
[ range]

0.17b

Protocol Visits Completed in Window per
Center (%)†*:
Median (25th, 75th percentile)
[ range]
Completed 1˚ Outcome Visits

† **

: n (%)

†
- only includes sites with randomized subjects (N=88)
*- of protocol visits that were completed
**- includes subjects who dropped prior to the primary outcome visit as not completed
a- Wilcoxon rank-sum test
b- repeated measures ANOVA
c- repeated measures logistic regression (GEE)
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0.38b

Comparisons of additional variables related to protocol adherence and variables
related to data collection are reported in Table 4. There was no significant difference in
number of protocol deviations, suggesting that protocol adherence in general is similar at the
two types of centers. In terms of data collection, there was no difference in number of
adverse events reported per subject, suggesting that reporting guidelines are being followed
similarly by the two types of centers. There was also no significant difference in number of
case report form edits, data queries from the Coordinating Center, or ungradable OCT
images. However, there was a significant difference in number of ungradable photographs (p
= 0.002) with community-based centers collecting a higher proportion of these poor quality
images.
TABLE 4. PROTOCOL ADHERENCE AND DATA COLLECTION ACCORDING TO CENTER TYPE†
VARIABLE

University Based

Community Based

P-Value

Ncenters = 35
Nsubjects = 207

Ncenters = 53
Nsubjects = 486

Median (25th, 75th
percentile)

Median (25th, 75th
percentile)

3 (1, 5)*

2 (1, 4)*

0.79a

23 (13, 40)

26 (14, 45)

0.79a

Data Queries per Subject

7 (5, 12)

8 (5, 13)

0.44a

Adverse Events per Subject

8 (4, 13)

7 (4, 12)

0.81a

N (%)

N (%)

Ungradable Photographs

45 (3)

197 (6)

0.002b

Ungradable OCTs

22 (1)

46 (1)

0.8 b

Protocol Adherence
Protocol Deviations per Subject
Data Collection
Case Report Form (CRF) Edits per Subject

†
All variables in table only include sites with randomized subjects (N = 88)
* 31 subjects at university-based centers and 62 subjects at community-based centers had 0 deviations
a- repeated measures ANOVA
b- repeated measures logistic regression (GEE)
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Variables related to center and personnel performance in completing Network
procedural requirements were examined to determine if there were differences by type of
center (Table 5). The time to become certified at community-based centers was significantly
lower than the time to become certified at university-based centers (p < 0.0001). The days
until investigator sign-off of case report forms was significantly higher for community-based
centers compared with university-based centers (p = 0.001). This difference remained
significant when centers were divided into low and high recruiters and center type was
compared within recruitment group. There was also a difference in days until sign-off of
protocol deviations ( p =0.02) and submission of OCTs (p=0.02), however these did not meet
the p <0.01 criterion used for statistical significance. There was no significant difference in
number of investigators who completed certification requirements per center, number of
conference calls attended per primary investigator, number of conference calls attended per
primary coordinator by center type, days until investigator sign-off of edits, or days until
submission of photographs (Table 5).
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TABLE 5. CENTER AND PERSONNEL PERFORMANCE ACCORDING TO CENTER TYPE
VARIABLE

University
Based

Community Based

N= 40

N = 62

208 (128, 247)

117 (77, 171)

[36-574]

[16-326]

2 (2, 3)

3 (2,3)

[1-7]

[1-11]

7 (0, 15)

8 (2, 11)

[0-27]

[0-22]

7 (1, 18)

7 (2, 15)

[0-33]

[0-28]

Of Case Report Forms

5 (0, 14)

7 (1, 19)

0.001b

Of Protocol Deviations

17 (7, 27)

19 (7, 40)

0.02b

Of CRF Edits

13 (4, 23)

12 (5, 27)

0.11b

Days until Submission of OCTs†

18 (8, 29)

12 (6, 26)

0.02b

Days until Submission of Photographs†

18 (11, 29)

12 (6, 25)

0.13b

P-Value

Days to Become Certified:
Median (25th, 75th percentile)
[ range]

<.0001a

Certified Investigators per Center:
Median (25th, 75th percentile)
[ range]

0.59a

Conference Calls Attended per Primary
Investigator:
Median (25th, 75th percentile)
[ range]

0.77a

Conference Calls Attended per Primary
Coordinator:
Median (25th, 75th percentile)
[ range]
Days until Investigator Sign-Off

0.76a

†

†
- only includes sites with randomized subjects (N=88)
a- Wilcoxon rank-sum test
b- repeated measures ANOVA
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CHAPTER 5. DISCUSSION
Summary of Findings
In general, university and community-based centers were similar in clinical trial
performance. One outcome measure that showed a statistically significant difference for
which community-based centers were superior was the number of days to become certified.
Outcome measures that showed a statistically significant difference for which universitybased centers were superior included days until sign-off of forms and number of ungradable
photographs. Although the difference in days until sign-off of deviations was statistically
significant, it is not believed that a difference of 2 days is practically important in terms of
clinical trial performance.
Confounding
Summary statistics for center and subject characteristics were evaluated for signs of
possible confounding. All subject characteristics were similar for the two center types. The
two center types varied by site region and population of the city in which the center is
located. However, outcome measures did not appear to differ by site region (data not
shown). City population was not evaluated further for confounding since it was unclear how
wide the recruitment pool for centers spread beyond city limits. It is likely that centers in
smaller cities see patients from nearby cities as well. Outcome measures also did not differ
by low and high recruitment. There are other possible confounders for which data were not
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available for evaluation in this study. These include but are not limited to experience of the
investigators and coordinators in previous clinical trials, monetary resources, or other
unknown factors.
Bias
Whenever the exposure variable is self-reported, as in this case, there is potential for
misclassification bias. However, the Coordinating Center reviewed the classification of
center type and it is unlikely that misclassification occurred. One factor to note is that
centers were self-selected for participation in the trial. These centers were interested in
conducting research and were confident that they could adhere to the necessary trial policies
and procedures. If instead, community-based centers were chosen at random by the sponsor
to participate, the trial performance of these centers may have been different.
Chance
Because of the large number of outcome variables being examined, multiple
comparisons in this study could have led to false positives. This is likely for variables that
were borderline significant including number of subjects recruited, days until sign-off of
protocol deviations, and days until submission of photographs (p = 0.05, 0.02, and 0.02
respectively).
Statistical vs. Practical Significance
Despite the limitations of multiple comparisons, it is believed that the differences in a
few variables are valid including days to become certified (p < 0.001), days until sign-off of
case report forms, (p = 0.001), and number of ungradable photographs (p = 0.002). Even
though these all meet the criterion for statistical significance, it is noted that only the
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difference in days to become certified and number of ungradable photographs have practical
significance for the success of the clinical trial. An average difference of two days in signoff of case report forms would not likely affect timely dissemination of the trial results.
External Validity
The results from the current study could likely be applied to other multi-center
networks in which the same centers participate in several studies, particularly other multicenter ophthalmology research groups. In this study, the centers had experience with the
DRCR.net’s procedures prior to beginning enrollment in the trial used in the analysis. The
results also may be less generalizable to a single study where multiple centers are recruited to
participate, as it is not clear if the two types of centers would have the same learning curve
for study-specific procedures. It is not clear whether the same conclusions would be found in
studies of other diseases. However, the same issues of trial performance affect studies of all
disease types.
Comparison to Other Studies
The most comparable study performed by Bressler, et al, also found that universitybased and community-based centers performed similarly when completing an ophthalmic
surgery clinical trial. The study included a smaller number of centers and therefore only
presented summary statistics. The current study further confirms that the two types of
centers are approximately equal in most aspects of clinical trial performance.
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Conclusion
Since community-based centers performed as well or better than university-based
centers in almost all measures of clinical trial performance, it is recommended that these
types of centers be considered more often for participation in clinical trial research. The two
aspects for which one type was deficient compared with the other should be addressed for
future studies. For instance, university-based centers typically take more time to become
certified because of obstacles with obtaining approval from the institutional review board and
negotiating detailed contracts between the university official and the sponsor for completion
of the trial. Community-based centers, on the other hand, are able to use the central IRB,
which typically has a quicker turn around time, and have less difficulty promptly setting up
contracts with a sponsor for completing trials. The lengthy process for obtaining IRB
approval and negotiating contracts at university-based centers needs to be addressed if these
centers want to stay involved in multi-center trial research. For community-based centers,
the fact that photograph quality was poorer than university-based centers suggests that further
training in certain data collection methods may be needed for these types of centers,
particularly if research experience is limited.
Public Health Implications
Allowing community-based centers to participate more often in clinical trials will
impact those patients who may not have had access to newer, experimental therapies
previously or would have had to change doctors to access such therapies. This will also
broaden the pool of study subjects in clinical trials, making study results more generalizable.
Since the time to become certified in the study was significantly lower for community-based
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centers than university-based centers, involving these centers may also be particularly useful
when studies need to be completed in a short time frame so that results can be disseminated
in a timely manner.
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